Resource

 

 

 

 

 

 

 

 

 

 

 

Finance & Banking

Osborne Clarke advises Investec Bank plc in its capacity as sponsor and financial adviser to Regus plc

04 Nov 2016

Osborne Clarke has advised Investec Bank plc in its capacity as sponsor and financial adviser to Regus plc in connection to its proposed establishment of a new holding company and headquarters move to Switzerland.

The transaction involves a scheme of arrangement of Regus, the leading global workplace provider, to interpose a new holding company, IWG plc, which will be listed on the premium listing segment of the Official List. The market capitalisation of IWG plc is likely to be c.£2.2 billion.

White & Case Advises Banks on PKO Bank Hipoteczny's €4 Billion Covered Bond Programme

04 Nov 2016

White & Case LLP has advised Société Générale as global coordinator, lead co-arranger and dealer, Deutsche Bank, J.P. Morgan and PKO Bank Polski as co-arrangers and dealers, and Landesbank Baden-Württemberg as dealer, on the establishment by PKO Bank Hipoteczny S.A., a subsidiary of PKO Bank Polski, of a €4 billion international covered bond issuance programme, and the issue of €500 million covered bonds thereunder.

White & Case Advises Bank Group on Air France-KLM's €400 Million Bond Issue

03 Nov 2016

Global law firm White & Case LLP has advised HSBC Bank plc and Société Générale, as global coordinators, and Citgroup Global Markets Limited, Commerzbank Aktiengesellschaft, Crédit Industriel et Commercial S.A. and Goldman Sachs International, as joint lead managers, on Air France-KLM's €400 million bond issue.

The bonds bear interest at a rate of 3.75 percent and will mature in October 2022. Issued on October 12, 2016, the bonds are listed on the regulated market of Euronext Paris.

White & Case Advises the Dealers, Joint Lead Managers and Dealer Managers on Snam's €10 Billion EMTN Programme Update, Issues of €1.2 Billion and €500 Million Notes and Related Tender Offer

03 Nov 2016

White & Case LLP has advised BNP Paribas, as arranger, and the other dealers, on the update of Snam S.p.A.'s €10 billion Medium Term Note Programme and on the issuances, under the same Programme, of €1.25 billion fixed rate Notes due 2026, and €500 million fixed rate Notes due 2020. Both issuances have been listed on the Luxembourg Stock Exchange and were sold to institutional investors.

White & Case Advises Bank Syndicates on Wendel's €635 Million Tender Offer and €300 Million Bond Issue

03 Nov 2016

White & Case LLP has advised bank syndicates on Wendel's tender offer to repurchase its 2017, 2018, 2019 and 2021 bond issues for a total of €635 million, and on Wendel's €300 million bond issue maturing in 6.5 years with a coupon of 1 per cent.

Wendel will use the net proceeds of the new issue for its general corporate purposes, to repurchase the bonds that have been tendered under the tender offer and to continue improving its financial structure.

Milbank Advises MLAs on Financing of Carlyle’s Investment in Logoplaste Group

03 Nov 2016

LONDON, 3 November, 2016 – Milbank, Tweed, Hadley & McCloy LLP advised the mandated lead arrangers on the financing package supporting The Carlyle Group’s majority investment in the Logoplaste Group, a global designer and manufacturer of value-added rigid plastic packaging solutions to a wide range of blue-chip clients with its origins in Portugal.

The London Leveraged Finance team was led by partner and practice head Suhrud Mehta and included of counsel Patrick Holmes, senior associates Jacob Durkin and Nike Johnson and associate Isabel Vickers.

King & Wood Mallesons Advises on CR Pharmaceutical’s Listing on HKSE— Hong Kong’s Largest IPO by Non-financial Enterprises in 2016

03 Nov 2016

China Resources Pharmaceutical Group Ltd. (“CR Pharmaceutical”, stock code: 3320) had its H shares listed on the main board of the Hong Kong Stock Exchange, with King & Wood Mallesons (KWM) advising its underwriters. CR Pharmaceutical issued a total of 1.543 billion shares globally on an offer price of HK$9.10 per share, and raised a net amount of approximately HK$13.671 billion, making it the largest IPO conducted by non-financial enterprises in Hong Kong’s capital market in 2016.

Slaughter and May advised International Finance Facility for Immunisation Company on its issuance of US$500 million Floating Rate Notes

03 Nov 2016

Slaughter and May advised International Finance Facility for Immunisation Company (“IFFIm”) on its issuance of US$500 million Floating Rate Notes due 2019 (the “Notes”) pursuant to its Global Debt Issuance Programme. The Notes provide investors with an opportunity to fund immunisation programmes by the GAVI Alliance, helping protect millions of children in the world's poorest countries against preventable diseases.